27 completed, 7 unknown, 5 terminated, 2 not yet recruiting. 23 Not applicable, 6 Phase 2, 5 Phase 1, 5 Phase 4, 3 Phase 3.
Follow Lifespan: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Digital Intervention Delivered Via Street Medicine to Increase HIV and Substance Use Care Among Survivors of Sex Trafficking CONNECT - Sex Trafficking, HIV | Early Phase 1 | Not yet recruiting | Lifespan | 60 | 2026-10-05 | 2026-07-13 |
| Stress Reactivity and Mother-Infant Cardiovascular Disease Risk Follow up to Mindfulness RCT using a Still Face Paradigm - Maternal Health, Infant Health | Not applicable | Not yet recruiting | Lifespan | 40 | 2026-04-15 | 2026-04-01 |
| Injectable Buprenorphine in Prison: A Preference Trial Brixadi (Injectable Buprenorphine), Sublocade - Opioid Use Disorder, Incarceration | Phase 4 | Recruiting | Lifespan | 60 | 2026-02-18 | 2026-05-15 |
| Implementing Low-Barrier HCV Treatment in a Jail Setting Sofosbuvir / Velpatasvir Oral Tablet [Epclusa], Community Health Worker - HEPATITIS C (HCV), Incarceration | Phase 4 | Recruiting | Lifespan | 40 | 2025-06-11 | 2026-02-27 |
| Online Tai Chi Plus Fitbit After ACS Tai chi + wearable - Acute Coronary Syndrome, Physical Inactivity | Phase 2 | Completed | Beth Israel Deaconess Medical Center | 70 | 2024-08-27 | 2026-08-06 |
| TMS for PTSD and Blood Pressure Transcranial magnetic stimulation - Post-traumatic Stress Disorder, Hypertension | Not applicable | Completed | Lifespan | 4 | 2024-02-15 | 2026-06-11 |
| Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant Degarelix, Gemcitabine/Cisplatin - Urothelial Carcinoma Bladder, Androgen Receptor Positive | Phase 1 | Terminated | Brown University | 2 | 2023-10-02 | 2026-04-02 |
| Integrated Alcohol and Sexual Assault Prevention for Bisexual Women REACH Program - Alcohol Use, Unspecified, Sexual Assault | Not applicable | Withdrawn | Lifespan | 2023-08-03 | 2025-03-26 | |
| Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: Qualitative Interviews Opioid Use Disorder, Criminal Justice | Unknown | Lifespan | 25 | 2023-07-01 | 2024-04-09 | |
| Reducing Alcohol Use and Sexual Dysfunction in Survivors of Sexual Trauma AWARE - Alcohol Use, Unspecified, Sexual Dysfunction | Not applicable | Completed | Lifespan | 86 | 2023-02-14 | 2026-04-29 |
| Project HOME: Home-Based Treatment Options and Mechanisms for Eating Disorders Family-based treatment (FBT), Integrative family therapy - Anorexia Nervosa, Eating Disorders | Not applicable | Completed | University of Pittsburgh | 77 | 2022-08-01 | 2026-06-03 |
| Mindfulness & Mechanisms Study Mindfulness training - Hypertension in Pregnancy | Not applicable | Active not recruiting | Lifespan | 150 | 2022-06-13 | 2026-08-25 |
| Effects of Tildrakizumab on Epigenetic Age TILDRAKIZUMAB - Psoriasis, Aging | Phase 4 | Completed | Carlos Wambier | 30 | 2022-04-08 | 2024-07-18 |
| BrUOG 390: Neoadjuvant Treatment With Talazoparib Talazoparib Oral Capsule - BRCA1 Mutation, BRCA2 Mutation | Phase 1 | Terminated | Brown University | 1 | 2021-03-29 | 2023-10-12 |
| Medication Maintenance Therapy in Community Pharmacy Settings buprenorphine/naloxone oral product, injectable naltrexone, Pharmacy maintenance addiction care - Opioid-use Disorder | Phase 2 / Phase 3 | Unknown | Lifespan | 250 | 2019-07-25 | 2022-08-24 |
| Symptom Management Implementation of Patient Reported Outcomes in Oncology Stakeholder Survey (Control Period), Stakeholder Survey (Intervention Period), Qualitative Interview - Other Cancer, Gastrointestinal Cancer | Not applicable | Completed | Dana-Farber Cancer Institute | 42808 | 2019-07-25 | 2025-08-27 |
| Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell Lung Durvalumab, SBRT - Stage III Non-small-cell Lung Cancer | Phase 2 | Completed | Brown University | 11 | 2019-05-13 | 2026-04-02 |
| Fat Grafting Technique for Fecal Incontinence Fat Grafting for Fecal Incontinence - Fecal Incontinence | Not applicable | Unknown | Melanie Salerno, RN | 10 | 2019-04-11 | 2020-07-09 |
| Prenatal Mindfulness & Hypertension Study Mindfulness Training - Hypertension in Pregnancy | Not applicable | Completed | Lifespan | 30 | 2019-04-01 | 2023-06-01 |
| Hydroxyurea Optimization Through Precision Study Hydroxyurea - Sickle Cell Disease, Sickle Cell Anemia | Phase 3 | Completed | Lifespan | 104 | 2019-01-17 | 2025-06-18 |
Showing 20 of 46. Sign in to see all of them.
Opioid-Related Disorders (4) · Alcohol Drinking (3) · Hypertension (3) · Neoplasm Metastasis (3) · Cardiovascular Diseases (2) · Heart Failure (2) · Hypertension, Pregnancy-Induced (2) · Pancreatic Neoplasms (2) · Urinary Bladder Neoplasms (2) · Abdominal Pain (1) · Acute Coronary Syndrome (1) · Acute Kidney Injury (1) · Agnosia (1) · Anemia, Sickle Cell (1) · Anorexia Nervosa (1)
Buprenorphine (3) · Albumin-Bound Paclitaxel (2) · Gemcitabine (2) · Oxaliplatin (2) · Alpelisib (1) · Bupivacaine (1) · Buprenorphine, Naloxone Drug Combination (1) · Calcium Dobesilate (1) · Capacity Building (1) · Capecitabine (1) · Cisplatin (1) · Community Health Workers (1) · Dexamethasone (1) · Fecal Microbiota Transplantation (1) · Hydroxyurea (1)
United States (44)
Howard Safran, MD (4) · Lindsay M. Orchowski, Ph.D. (2) · Andrea B Goldschmidt, Ph.D. (1) · Anthony Mega, MD (1) · Bruce M Becker (1) · Carlos G Wambier, MD, PhD (1) · Colleen Kelly, M.D. (1) · Don S Dizon, MD (1) · Elizabeth Donovan, PhD (1) · Geoffrey W Wilson, M.D. (1) · Hina Khan, MD (1) · Justin Berk, MD (1) · Kittichai Promrat, M.D. (1) · Linda J Resnik, PhD MS (1) · Marcia W VanVleet, MD, MPH (1)
PMID 21157303, PMID 21854488, PMID 23876346, PMID 24408869, PMID 24535092, PMID 25035570, PMID 25425411, PMID 26322819, PMID 27122541, PMID 29980460, PMID 30969332, PMID 31452053, PMID 31463699, PMID 33246482, PMID 34195206, PMID 34985914, PMID 36621212, PMID 36630629, PMID 37751286, PMID 37995129, PMID 38011613, PMID 38302281, PMID 38445744, PMID 38976481, PMID 39486014, PMID 39533260, PMID 40257368, PMID 40505593, PMID 40524282, PMID 40631021, PMID 40645369, PMID 41027703, PMID 41941188, PMID 42617697
K23DA055695 (2), 1UM1CA233080-01 (1), P20GM103652 (1), R34DA061732 (1), R34MH123589 (1), U54GM115677 (1)